KRISTEN LASSEIGNE: Open Payments
NPI 1912468083 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 43 payments from 13 companies in 2025. Trend: 2023 $653 · 2024 $710 · 2025 $714
Food & beverage: $695Education: $18
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $181 |
| Madrigal Pharmaceuticals | 3 | $72 |
| Janssen Biotech, Inc. | 2 | $64 |
| GENZYME CORPORATION | 2 | $62 |
| Ardelyx, Inc. | 3 | $60 |
| Gilead Sciences, Inc. | 3 | $58 |
| Ipsen Biopharmaceuticals, Inc | 3 | $57 |
| Phathom Pharmaceuticals, Inc. | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Boston Scientific Corporation | 1 | $26 |
Products named: CREON, REZDIFFRA, TREMFYA, DUPIXENT, IBSRELA, IQIRVO, SKYRIZI, VOQUEZNA.
Industry payments across LA — which companies pay providers there.
